Vascular protective actions of a nitric oxide aspirin analog in both in vitro and in vivo models of diabetes mellitus

被引:39
作者
Pieper, GM
Siebeneich, W
Olds, CL
Felix, CC
Del Soldato, P
机构
[1] Med Coll Wisconsin, Div Transplant Surg, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Biophys Res Inst, Milwaukee, WI 53226 USA
[4] NicOx SA, Sophia Antipolis, France
关键词
diabetes mellitus; endothelium; nitric oxide; hydroxyl radical; superoxide; aspirin; nuclear factor kappa B; lipid peroxides; electron spin resonance spectroscopy; hyperglycemia; free radicals;
D O I
10.1016/S0891-5849(02)00832-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Defective endothelium-dependent relaxation is observed in experimental and human diabetes mellitus. The nature of this defect is not fully understood but may involve decreased nitric oxide (NO) bioactivity due to enhanced production of reactive oxygen species (ROS). In this paper, we examine the benefits and actions of a novel NO-donating, antioxidant called 2-acetoxybenzoic acid 2-(2-nitrooxymethyl) phenyl ester, and denoted as NCX4016, on NO-mediated endothelium-dependent relaxation in normal arteries exposed to acute elevations in glucose or in arteries derived from chronic diabetic animals. Material and Methods: Intrinsic free radical scavenging by NO-NSAIDs in solution were evaluated using electron paramagnetic resonance (EPR) spectroscopy and spin trapping with 5,5-dimethyl-1-pyrroline-N-oxide (DNIPO). In acute studies, normal rat aortas were exposed in tissue culture for 18 h to 5.5 mM or 40 mM in the presence or absence of NCX4016, a NO-donating NSAID unrelated to aspirin (NCX2216) or aspirin. Vascular reactivity of thoracic aortic rings to endothelium-dependent relaxation to acetylcholine in vitro was determined. For chronic hyperglycemia, diabetes was induced in rats by intravenous injection with streptozotocin. Vascular reactivity of thoracic aortic rings to endothelium-dependent relaxation to acetylcholine in vitro was determined after 8 wks in untreated animals or animals chronically-treated with NCX4016. Antioxidant efficacy in vivo was determined by measurement of plasma isoprostanes and by nuclear binding activity of NF-kappaB in nuclear fractions of aortae. Results: Incubation with NCX4016 and NCX2216 produced a concentration-dependent inhibition of DMPO-OH formation indicating scavenging of hydroxyl radicals (HO.). In contrast, little efficacy to scavenge superoxide anion radicals was noted. Acute incubation of normal arteries with elevated glucose concentration caused inhibition of normal relaxation to acetylcholine. This impairment was prevented by coincubation with NCX4106 but not by mannitol, the parent compound (aspirin) or by NCX2216. In addition, chronic treatment with NCX4016 prevented die development of defective endothelium-dependent relaxation to acetylcholine, This protection did not occur as a result to any changes in blood glucose concentration or hemoglobin glycation. Treatment with NCX4016 did decrease the elevation in plasma isoprostanes and normalized the diabetes-induced increase in NF-kappaB binding activity in nuclear fractions derived from aortic tissue. Conclusions: Collectively, these studies suggest that antioxidant interventions using NO-donating NSAIDs may provide an important novel therapeutic strategy to protect the diabetic endothelium. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:1143 / 1156
页数:14
相关论文
共 86 条
[1]   Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin - Possible mechanisms involved [J].
Angulo, J ;
SanchezFerrer, CF ;
Peiro, C ;
Marin, J ;
RodriguezManas, L .
HYPERTENSION, 1996, 28 (04) :583-592
[2]  
Archibald V, 1996, N-S ARCH PHARMACOL, V353, P584
[3]   Nitric oxide inhibits the formation of advanced glycation end products [J].
Asahi, K ;
Ichimori, K ;
Nakazawa, H ;
Izuhara, Y ;
Inagi, R ;
Watanabe, T ;
Miyata, T ;
Kurokawa, K .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1780-1787
[4]   TOPICAL HYPERGLYCEMIA RAPIDLY SUPPRESSES EDRF-MEDIATED VASODILATION OF NORMAL RAT ARTERIOLES [J].
BOHLEN, HG ;
LASH, JM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01) :H219-H225
[5]   Nitrosylhemoglobin, an unequivocal index of nitric oxide release from nitroaspirin: in vitro and in vivo studies in the rat by ESR spectroscopy [J].
Carini, M ;
Aldini, G ;
Stefani, R ;
Orioli, M ;
Facino, RM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (04) :509-518
[6]   Nitric oxide and vascular responses in Type I diabetes [J].
Chan, NN ;
Vallance, P ;
Colhoun, HM .
DIABETOLOGIA, 2000, 43 (02) :137-147
[7]  
CHANG KC, 1993, J PHARMACOL EXP THER, V266, P992
[8]  
CHURCHMAN A, 2001, INFLAMM RES, V50, P211
[9]  
Cook SP, 2001, CIRCULATION, V104, P208
[10]   Myocardial nuclear factor-κB activity and nitric oxide production in rejecting cardiac allografts [J].
Cooper, M ;
Lindholm, P ;
Pieper, G ;
Seibel, R ;
Moore, G ;
Nakanishi, A ;
Dembny, K ;
Komorowski, R ;
Johnson, C ;
Adams, M ;
Roza, A .
TRANSPLANTATION, 1998, 66 (07) :838-844